| Cadia Healthcare - Annapolis | |
| 900 Van Buren Street, Annapolis, Maryland 21403 | |
| (410) 267-8653 | |
| Name | Cadia Healthcare - Annapolis |
|---|---|
| Location | 900 Van Buren Street, Annapolis, Maryland |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 97 |
| Occupancy Rate | 74.43% |
| Medicare ID (CCN) | 215005 |
| Legal Business Name | Wye Oak Healthcare Of Annapolis Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1265439004 |
| Organization Name | NEW ANNAPOLIS NURSING LLC |
| Address | 900 Van Buren St, Annapolis, MD 21403 |
| Phone Number | 301-858-5810 |
News Archive
Manchester United's Paul Scholes is backing the UK's Department of Health flu immunisation campaign, which launched today.
Pacira Pharmaceuticals, Inc. today announced findings from the completed first part of its Phase 2/3 clinical trial assessing the use and administration of EXPAREL (bupivacaine liposome injectable suspension) as a single-dose injection femoral nerve block for total knee arthroplasty surgery.
Several studies have shown that hospitalized patients still have unacceptably high rates of harm and injury due in part to limited access for quality staff to obtain primary care data from electronic medical records. As a result, hospital incident reports do not capture most harm that occurs in hospitals.
Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches are needed. Given the success of local therapies, as opposed to intravenous systemic therapies, for liver diseases (such as hepatocellular carcinoma), it is thought that similar local therapies may benefit patients with pancreatic cancer. To develop such therapies, it would be useful to devise targets that are easy to obtain and can indicate the efficacy of these new therapies in models of pancreatic cancer.
› Verified 7 days ago
| NPI Number | 1780399667 |
| Organization Name | COMPLETE CARE AT ANNAPOLIS LLC |
| Address | 900 Van Buren St, Annapolis, MD 21403 |
| Phone Number | 410-267-8653 |
News Archive
Manchester United's Paul Scholes is backing the UK's Department of Health flu immunisation campaign, which launched today.
Pacira Pharmaceuticals, Inc. today announced findings from the completed first part of its Phase 2/3 clinical trial assessing the use and administration of EXPAREL (bupivacaine liposome injectable suspension) as a single-dose injection femoral nerve block for total knee arthroplasty surgery.
Several studies have shown that hospitalized patients still have unacceptably high rates of harm and injury due in part to limited access for quality staff to obtain primary care data from electronic medical records. As a result, hospital incident reports do not capture most harm that occurs in hospitals.
Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches are needed. Given the success of local therapies, as opposed to intravenous systemic therapies, for liver diseases (such as hepatocellular carcinoma), it is thought that similar local therapies may benefit patients with pancreatic cancer. To develop such therapies, it would be useful to devise targets that are easy to obtain and can indicate the efficacy of these new therapies in models of pancreatic cancer.
› Verified 7 days ago
| NPI Number | 1932620440 |
| Organization Name | WYE OAK HEALTHCARE OF ANNAPOLIS, LLC |
| Address | 900 Van Buren St, Annapolis, MD 21403 |
| Phone Number | 484-731-2500 |
News Archive
Manchester United's Paul Scholes is backing the UK's Department of Health flu immunisation campaign, which launched today.
Pacira Pharmaceuticals, Inc. today announced findings from the completed first part of its Phase 2/3 clinical trial assessing the use and administration of EXPAREL (bupivacaine liposome injectable suspension) as a single-dose injection femoral nerve block for total knee arthroplasty surgery.
Several studies have shown that hospitalized patients still have unacceptably high rates of harm and injury due in part to limited access for quality staff to obtain primary care data from electronic medical records. As a result, hospital incident reports do not capture most harm that occurs in hospitals.
Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches are needed. Given the success of local therapies, as opposed to intravenous systemic therapies, for liver diseases (such as hepatocellular carcinoma), it is thought that similar local therapies may benefit patients with pancreatic cancer. To develop such therapies, it would be useful to devise targets that are easy to obtain and can indicate the efficacy of these new therapies in models of pancreatic cancer.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Manchester United's Paul Scholes is backing the UK's Department of Health flu immunisation campaign, which launched today.
Pacira Pharmaceuticals, Inc. today announced findings from the completed first part of its Phase 2/3 clinical trial assessing the use and administration of EXPAREL (bupivacaine liposome injectable suspension) as a single-dose injection femoral nerve block for total knee arthroplasty surgery.
Several studies have shown that hospitalized patients still have unacceptably high rates of harm and injury due in part to limited access for quality staff to obtain primary care data from electronic medical records. As a result, hospital incident reports do not capture most harm that occurs in hospitals.
Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches are needed. Given the success of local therapies, as opposed to intravenous systemic therapies, for liver diseases (such as hepatocellular carcinoma), it is thought that similar local therapies may benefit patients with pancreatic cancer. To develop such therapies, it would be useful to devise targets that are easy to obtain and can indicate the efficacy of these new therapies in models of pancreatic cancer.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 21.94 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.76 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 38.36 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.77 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.87 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 8.42 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.11 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.62 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 15.34 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 73.57 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.16 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 30.69 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.3 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 17.18 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.61 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 87.56 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.33 | 82.93 |
News Archive
Manchester United's Paul Scholes is backing the UK's Department of Health flu immunisation campaign, which launched today.
Pacira Pharmaceuticals, Inc. today announced findings from the completed first part of its Phase 2/3 clinical trial assessing the use and administration of EXPAREL (bupivacaine liposome injectable suspension) as a single-dose injection femoral nerve block for total knee arthroplasty surgery.
Several studies have shown that hospitalized patients still have unacceptably high rates of harm and injury due in part to limited access for quality staff to obtain primary care data from electronic medical records. As a result, hospital incident reports do not capture most harm that occurs in hospitals.
Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches are needed. Given the success of local therapies, as opposed to intravenous systemic therapies, for liver diseases (such as hepatocellular carcinoma), it is thought that similar local therapies may benefit patients with pancreatic cancer. To develop such therapies, it would be useful to devise targets that are easy to obtain and can indicate the efficacy of these new therapies in models of pancreatic cancer.
› Verified 7 days ago
Cadia Healthcare - Annapolis Location: 900 Van Buren Street, Annapolis, Maryland 21403 Phone: (410) 267-8653 | |
Autumn Lake Healthcare At Spa Creek Location: 35 Milkshake Lane, Annapolis, Maryland 21403 Phone: (410) 269-5100 | |
Heritage Harbour Health And Rehabilitation Center Location: 2700 South Haven Road, Annapolis, Maryland 21401 Phone: (410) 897-1300 | |